文献速递牙体牙髓病

MTA与预混硅酸钙水门汀部分活髓切断术的两年随机对照试验结果

Two-Year Outcome of Partial Pulpotomy Using Mineral Trioxide Aggregate or a Premixed Calcium Silicate Cement: A Randomized Clinical Trial.
PubMed 文献 · Int Endod J · 2026-09-18

这项随机临床试验在139颗成熟下颌磨牙深龋伴牙髓炎患牙中比较White MTA Angelus与预混硅酸钙水门汀NeoPutty行部分活髓切断术的24个月疗效,两组成功率分别为90.6%和92.0%,差异无统计学意义(p=0.774),总体成功率91.4%,止血时间与治疗结局显著相关。

要点

  • White MTA Angelus与NeoPutty行部分活髓切断术24个月成功率均较高且组间无显著差异。
  • 止血时间与治疗结局显著相关,术前Wolters牙髓诊断分类与结局无显著关联。
  • 两组24个月临床与影像学成功率分别为90.6%和92.0%,总体为91.4%。

核心结论

  • White MTA Angelus与NeoPutty行部分活髓切断术在24个月均获得较高的临床和影像学成功率,止血时间而非术前Wolters牙髓诊断与治疗结局显著相关。

研究设计与样本

  • 随机临床试验,纳入成人患者139颗成熟永久下颌磨牙,影像学深龋病变距牙髓0-1.5 mm,按Wolters分类诊断为初期、轻度、中度或重度牙髓炎,White MTA Angelus组n=64,NeoPutty组n=75。

主要发现

  • 139颗治疗牙全部完成24个月随访,回访率100%。
  • White MTA Angelus组临床与影像学成功率为90.6%,NeoPutty组为92.0%,组间差异无统计学意义(p=0.774)。
  • 总体成功率为91.4%。
  • 止血时间与治疗结局显著相关(比值比=0.623;95%CI:0.429-0.905;p=0.013)。
  • 术前Wolters分类牙髓诊断与治疗结局无显著关联。

关键数值与推荐

  • 成功判定采用预设的成功标准,于24个月评估临床与影像学结局。
  • 止血时间与治疗结局的关联:比值比=0.623;95%CI:0.429-0.905;p=0.013。
  • 两组成功率比较:p=0.774。

临床怎么用

  • 对成熟下颌磨牙深龋伴牙髓炎行部分活髓切断术时,White MTA Angelus与NeoPutty均可作为可选材料,24个月成功率相近。
  • 操作中应关注止血时间,因其与治疗结局显著相关。

局限性

  • 原文结论表述为「在本研究局限性内」,具体局限性内容未在摘要中报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To compare the clinical and radiographic outcomes of partial pulpotomy performed with mineral trioxide aggregate (White MTA Angelus) or a premixed calcium silicate-based putty cement (NeoPutty) in mature mandibular molars with deep carious lesions and to explore factors associated with treatment outcome. METHODOLOGY: In this randomized clinical trial, 139 mature permanent mandibular molars in adult patients (median age 36 years), presenting with deep carious lesions located within 0-1.5 mm from the pulp on radiographic examination and diagnosed with initial, mild, moderate or severe pulpitis according to the Wolters classification, underwent partial pulpotomy using White MTA Angelus (n = 64) or NeoPutty (n = 75). Clinical and radiographic outcomes were assessed after 24 months using predefined success criteria. Multivariable analyses were performed to explore factors associated with treatment outcome. RESULTS: All 139 treated teeth completed the 24-month follow-up (100% recall rate). Clinical and radiographic success rates were 90.6% for White MTA Angelus and 92.0% for NeoPutty, with no statistically significant difference between groups (p = 0.774). The overall success rate was 91.4%. Haemostasis time was significantly associated with treatment outcome (odds ratio = 0.623; 95% confidence interval: 0.429-0.905; p = 0.013), whereas preoperative pulpal diagnosis according to the Wolters classification was not significantly associated with treatment outcome. CONCLUSIONS: Partial pulpotomy achieved high 24-month clinical and radiographic success with both White MTA Angelus and NeoPutty. Within the limitations of this study, haemostasis time, but not preoperative pulpal diagnosis according to the Wolters classification, was significantly associated with treatment outcome. TRIAL REGISTRATION: This study was registered at ClinicalTrials.gov (NCT06881615).

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Serrano A, Nogueira Leal Silva EJ, Duncan HF, et al. Two-Year Outcome of Partial Pulpotomy Using Mineral Trioxide Aggregate or a Premixed Calcium Silicate Cement: A Randomized Clinical Trial. Int Endod J. 2026. PMID: 42755412. doi:10.1111/iej.70274

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。